all report title image

ANTI MALARIAL DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Anti-malarial Drugs Market, By Drug Class (Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and Sulfones, and Others), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

  • Published In: 31 Mar, 2026
  • Code: CMI3726
  • Page number: 162
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Anti-malarial Drugs Market, By Drug Class, 2021 - 2033 (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Aminoquinolines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Quinoline-methanol (4-quinolinemethanols)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Cinchona Alkaloids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Biguanides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Sulfonamides and sulfones
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  5. Global Anti-malarial Drugs Market, By Route of Administration, 2021 - 2033 (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  6. Global Anti-malarial Drugs Market, By Distribution Channel, 2021 - 2033 (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  7. Global Anti-malarial Drugs Market, By Region, 2021 - 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033(%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
    • North America
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape

    • Company Profiles
      • Ipca Laboratories Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Zydus Group
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GSK plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cipla Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      •  Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Alvizia Health Care
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • F. Hoffmann-La Roche Ltd
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.